December 27, 2018 Media Coverage from ARCH Venture Partners | Share Forbes Identifies ARCH as a 2018 Top Healthcare Investor
November 19, 2018 Portfolio News from ARCH Venture Partners | Share Leaders of ARCH-backed Nebula Named to Forbes’ 30 Under 30
November 6, 2018 Portfolio News from ARCH Venture Partners | Share Twist Bioscience IPO Hauls In $70M for DNA Synthesis Technology
October 17, 2018 Portfolio News from ARCH Venture Partners | Share Eyeing NASH, Glympse Raises $22M to Test Disease Detection Nanotech
July 20, 2018 Portfolio News from ARCH Venture Partners | Share Rubius Therapeutics Announces Pricing of Initial Public Offering
May 24, 2018 Portfolio News from ARCH Venture Partners | Share Brii Biosciences Launches to Bring Innovative Medicines to Chinese Patients
May 21, 2018 Portfolio News from ARCH Venture Partners | Share GRAIL Announces $300 Million Raised in Oversubscribed Series C Financing
May 15, 2018 Media Coverage from ARCH Venture Partners | Share Co-founder and Managing Director Robert Nelsen Speaks with Xconomy on Biotech and Big Pharma
May 15, 2018 Portfolio News from ARCH Venture Partners | Share Nohla Therapeutics Announces Closing of $45 Million Series B Financing
May 14, 2018 Portfolio News from ARCH Venture Partners | Share Beam Therapeutics Founded by Gene Editing Pioneers to Create Precision Genetic Medicines with Base Editing
May 8, 2018 Portfolio News from ARCH Venture Partners | Share CStone Raises $260 million in Series B Financing to Advance Novel Cancer Therapies
